(Stroke. 2000;31:77.)
© 2000 American Heart Association, Inc.
Original Contributions |
Treating Acute Stroke Patients With Intravenous tPA
The OSF Stroke Network Experience
From the OSF Stroke Network and Department of Neuroscience at OSF Saint Francis Medical Center, Peoria, Ill (D.Z.W., J.A.R., D.S.H., D.J.G., J.C.M.), and Departments of Neurology (D.Z.W., D.J.G., J.C.M.) and Biomedical and Therapeutic Sciences (D.Z.W., J.C.M.), University of Illinois College of Medicine at Peoria.
Correspondence to Dr David Z. Wang, Director, OSF Stroke Network, 503 NE Glen Oak, Peoria, IL 61637. E-mail dwang{at}uic.edu
Background and Purpose—Since the FDA approved tissue plasminogen activator (tPA) in 1996 for acute ischemic stroke, few data have been obtained during the postmarketing phase, and applicability in rural hospitals does not exist. We attempt to examine the safety and outcome of intravenous tPA for acute ischemic stroke in the OSF Stroke Network.
Methods—Fifty-seven consecutive patients treated with tPA were examined from June 1996 through December 1998. Admission and discharge National Institute of Health Stroke Scales (NIHSS), modified Rankin Scales (MRS), and discharge disposition, as well as intracerebral hemorrhage and mortality rates, were compared.
Results—Of 20 network hospitals, 12 had the experience of administering tPA. No statistically significant differences in the variables recorded were observed for patients treated at the community hospitals versus those who received tPA at the tertiary medical center. In 35% of patients, tPA was initiated by an emergency room or primary care physician in consultation with an OSF neurologist. At discharge, 47% of the patients had minimal or no disability (MRS, 0 to 1), 44% had an NIHSS score of 0 or 1, 54% went home, 25% were transferred to in-patient rehabilitation, 12% went to a nursing or skilled-care facility, and 9% died. Intracerebral hemorrhage rate was 9%; 5% were symptomatic.
Conclusions—tPA can be administered safely with good outcome at community and rural hospitals. The OSF Stroke Network can serve as a model to assist small community hospitals to set up stroke programs and deliver up-to-date, acute stroke therapies.
Key Words: stroke, ischemic • thrombolysis • tissue plasminogen activator
This article has been cited by other articles:
 |
|
 |
|
  D. T. Laskowitz, S. E. Kasner, J. Saver, K. S. Remmel, E. C. Jauch, and BRAIN Study Group Clinical Usefulness of a Biomarker-Based Diagnostic Test for Acute Stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) Study Stroke, January 1, 2009; 40(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Alberts, R. A. Felberg, L. R. Guterman, S. R. Levine, and for Writing Group 4 Atherosclerotic Peripheral Vascular Disease Symposium II: Stroke Intervention: State of the Art Circulation, December 16, 2008; 118(25): 2845 - 2851. [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Leira, D. C. Hess, J. C. Torner, and H. P. Adams Jr Rural-Urban Differences in Acute Stroke Management Practices: A Modifiable Disparity Arch Neurol, July 1, 2008; 65(7): 887 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Acker III, A. M. Pancioli, T. J. Crocco, M. K. Eckstein, E. C. Jauch, H. Larrabee, N. M. Meltzer, W. C. Mergendahl, J. W. Munn, S. M. Prentiss, et al. Implementation Strategies for Emergency Medical Services Within Stroke Systems of Care: A Policy Statement From the American Heart Association/ American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council Stroke, November 1, 2007; 38(11): 3097 - 3115. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schwab, B. Vatankhah, C. Kukla, M. Hauchwitz, U. Bogdahn, A. Furst, H. J. Audebert, M. Horn, and On behalf of the TEMPiS Group Long-term outcome after thrombolysis in telemedical stroke care Neurology, August 28, 2007; 69(9): 898 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Kent, H. P. Selker, R. Ruthazer, E. Bluhmki, and W. Hacke The Stroke-Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke Stroke, December 1, 2006; 37(12): 2957 - 2962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Audebert, C. Kukla, B. Vatankhah, B. Gotzler, J. Schenkel, S. Hofer, A. Furst, and R. L. Haberl Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers: The Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany Stroke, July 1, 2006; 37(7): 1822 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamaguchi, E. Mori, K. Minematsu, J. Nakagawara, K. Hashi, I. Saito, Y. Shinohara, and for the Japan Alteplase Clinical Trial (J-ACT) Gro Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset: Japan Alteplase Clinical Trial (J-ACT) * Supplemental Appendix 2 Stroke, July 1, 2006; 37(7): 1810 - 1815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Z. Bambauer, S. C. Johnston, D. E. Bambauer, and J. A. Zivin Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol, May 1, 2006; 63(5): 661 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bandera, M. Botteri, C. Minelli, A. Sutton, K. R. Abrams, and N. Latronico Cerebral Blood Flow Threshold of Ischemic Penumbra and Infarct Core in Acute Ischemic Stroke: A Systematic Review Stroke, May 1, 2006; 37(5): 1334 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.G. Gonzalez Imaging-guided acute ischemic stroke therapy: From "time is brain" to "physiology is brain". AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 728 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Z. Deng, M. J. Reeves, B. S. Jacobs, G. L. Birbeck, R. U. Kothari, S. L. Hickenbottom, A. J. Mullard, S. Wehner, K. Maddox, A. Majid, et al. IV tissue plasminogen activator use in acute stroke: Experience from a statewide registry Neurology, February 14, 2006; 66(3): 306 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Bateman, H. C. Schumacher, B. Boden-Albala, M. F. Berman, J.P. Mohr, R. L. Sacco, and J. Pile-Spellman Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients: An Analysis of the Nationwide Inpatient Sample 1999 to 2002 Stroke, February 1, 2006; 37(2): 440 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Hess, S. Wang, W. Hamilton, S. Lee, C. Pardue, J. L. Waller, H. Gross, F. Nichols, C. Hall, and R. J. Adams REACH: Clinical Feasibility of a Rural Telestroke Network Stroke, September 1, 2005; 36(9): 2018 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Alberts, R. E. Latchaw, W. R. Selman, T. Shephard, M. N. Hadley, L. M. Brass, W. Koroshetz, J. R. Marler, J. Booss, R. D. Zorowitz, et al. Recommendations for Comprehensive Stroke Centers: A Consensus Statement From the Brain Attack Coalition Stroke, July 1, 2005; 36(7): 1597 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Qureshi, J. F. Kirmani, M. A. Sayed, A. Safdar, S. Ahmed, R. Ferguson, L. A. Hershey, K. J. Qazi, and for the Buffalo Metropolitan Area and Erie County Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke Neurology, June 28, 2005; 64(12): 2115 - 2120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Jacobs, P. L. Baker, C. Roychoudhury, R. H. Mehta, and S. R. Levine Improved Quality of Stroke Care for Hospitalized Medicare Beneficiaries in Michigan Stroke, June 1, 2005; 36(6): 1227 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Paul Coverdell Prototype Registries Writing Gr Acute Stroke Care in the US: Results from 4 Pilot Prototypes of the Paul Coverdell National Acute Stroke Registry Stroke, June 1, 2005; 36(6): 1232 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Hill, A. M. Buchan, and for The Canadian Alteplase for Stroke Effectivenes Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study Can. Med. Assoc. J., May 10, 2005; 172(10): 1307 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Task Force Members, L. H. Schwamm, A. Pancioli, J. E. Acker III, L. B. Goldstein, R. D. Zorowitz, T. J. Shephard, P. Moyer, M. Gorman, S. C. Johnston, et al. Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems Stroke, March 1, 2005; 36(3): 690 - 703. [Full Text] [PDF]
|
|
|
|
|
|
L. H. Schwamm, A. Pancioli, J. E. Acker III, L. B. Goldstein, R. D. Zorowitz, T. J. Shephard, P. Moyer, M. Gorman, S. C. Johnston, P. W. Duncan, et al. Recommendations for the Establishment of Stroke Systems of Care: Recommendations From the American Stroke Association's Task Force on the Development of Stroke Systems Circulation, March 1, 2005; 111(8): 1078 - 1091. [Full Text] [PDF]
|
|
|
|
|
|
M. Kaste Thrombolysis: What More Does It Take? Stroke, February 1, 2005; 36(2): 200 - 202. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Frey, H. K. Jahnke, P. W. Goslar, S. Partovi, and M. S. Flaster tPA by telephone: Extending the benefits of a comprehensive stroke center Neurology, January 11, 2005; 64(1): 154 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. U. Heuschmann, P. L. Kolominsky-Rabas, J. Roether, B. Misselwitz, K. Lowitzsch, J. Heidrich, P. Hermanek, C. Leffmann, M. Sitzer, M. Biegler, et al. Predictors of In-Hospital Mortality in Patients With Acute Ischemic Stroke Treated With Thrombolytic Therapy JAMA, October 20, 2004; 292(15): 1831 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Ingall, W. M. O'Fallon, K. Asplund, L. R. Goldfrank, V. S. Hertzberg, T. A. Louis, and T. J. H. Christianson Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial Stroke, October 1, 2004; 35(10): 2418 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 483S - 512S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wang, H. Gross, S. B. Lee, C. Pardue, J. Waller, F. T. Nichols III, R. J. Adams, and D. C. Hess Remote Evaluation of Acute Ischemic Stroke in Rural Community Hospitals in Georgia Stroke, July 1, 2004; 35(7): 1763 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Graham Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice: A Meta-Analysis of Safety Data Stroke, December 1, 2003; 34(12): 2847 - 2850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Handschu, R. Littmann, U. Reulbach, C. Gaul, J. G. Heckmann, B. Neundorfer, and M. Scibor Telemedicine in Emergency Evaluation of Acute Stroke: Interrater Agreement in Remote Video Examination With a Novel Multimedia System Stroke, December 1, 2003; 34(12): 2842 - 2846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wiborg and B. Widder Teleneurology to Improve Stroke Care in Rural Areas: The Telemedicine in Stroke in Swabia (TESS) Project Stroke, December 1, 2003; 34(12): 2951 - 2956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Crome and M. Bahr Editorial Comment--Remote Evaluation of Acute Ischemic Stroke: A Reliable Tool to Extend Tissue Plasminogen Activator Use to Community and Rural Stroke Patients? Stroke, October 1, 2003; 34 (10): e191 - e192. [Full Text] [PDF]
|
|
|
|
|
|
M. M. Rymer, D. Thurtchley, and D. Summers Expanded Modes of Tissue Plasminogen Activator Delivery in a Comprehensive Stroke Center Increases Regional Acute Stroke Interventions Stroke, June 1, 2003; 34 (6): e58 - e60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. U. Heuschmann, K. Berger, B. Misselwitz, P. Hermanek, C. Leffmann, M. Adelmann, H.-J. Buecker-Nott, J. Rother, B. Neundoerfer, and P. L. Kolominsky-Rabas Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality: The German Stroke Registers Study Group Stroke, May 1, 2003; 34(5): 1106 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nighoghossian Editorial Comment--tPA in Daily Clinical Practice Stroke, May 1, 2003; 34(5): 1112 - 1113. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Silliman, B. Quinn, V. Huggett, and J. G. Merino Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents Stroke, March 1, 2003; 34(3): 729 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Niessen, T. Hilger, M. Hoehn, and K.-A. Hossmann Thrombolytic Treatment of Clot Embolism in Rat: Comparison of Intra-arterial and Intravenous Application of Recombinant Tissue Plasminogen Activator Stroke, December 1, 2002; 33(12): 2999 - 3005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ruland, P. B. Gorelick, M. Schneck, D. Kim, C. G. Moore, S. Leurgans, and A. Bhardwaj Acute Stroke Care in Illinois: A Statewide Assessment of Diagnostic and Treatment Capabilities * Editorial Comment: A Statewide Assessment of Diagnostic and Treatment Capabilities Stroke, May 1, 2002; 33(5): 1334 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Taylor, G. D. Hughes, and R. J. Garrison Cardiovascular Disease Among Women Residing in Rural America: Epidemiology, Explanations, and Challenges Am J Public Health, April 1, 2002; 92(4): 548 - 551. [Abstract] [Full Text]
|
|
|
|
|
|
J. N. Fink, M. H. Selim, S. Kumar, B. Silver, I. Linfante, L. R. Caplan, and G. Schlaug Is the Association of National Institutes of Health Stroke Scale Scores and Acute Magnetic Resonance Imaging Stroke Volume Equal for Patients With Right- and Left-Hemisphere Ischemic Stroke? Stroke, April 1, 2002; 33(4): 954 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Merino, B. Silver, E. Wong, B. Foell, B. Demaerschalk, A. Tamayo, F. Poncha, and V. Hachinski Extending Tissue Plasminogen Activator Use to Community and Rural Stroke Patients Stroke, January 1, 2002; 33(1): 141 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Demchuk, D. Tanne, M. D. Hill, S. E. Kasner, S. Hanson, M. Grond, and S. R. Levine Predictors of good outcome after intravenous tPA for acute ischemic stroke Neurology, August 14, 2001; 57(3): 474 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Gladstone and S. E. Black Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice Can. Med. Assoc. J., August 1, 2001; 165(3): 311 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Reed, S. C. Cramer, D. K. Blough, K. Meyer, J. G. Jarvik, and D. Z. Wang Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals Editorial Comment Stroke, August 1, 2001; 32(8): 1832 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-C. Koennecke, R. Nohr, S. Leistner, and P. Marx Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience Stroke, May 1, 2001; 32(5): 1074 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.T. Akins, C. Delemos, D. Wentworth, J. Byer, S.J. Schorer, and a. R.P. Atkinson Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke? Neurology, December 26, 2000; 55(12): 1801 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Chapman, A. R. Woolfenden, D. Graeb, D. C. C. Johnston, J. Beckman, M. Schulzer, and P. A. Teal Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke : A Canadian Hospital's Experience Stroke, December 1, 2000; 31(12): 2920 - 2924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Brott and J. Bogousslavsky Treatment of Acute Ischemic Stroke N. Engl. J. Med., September 7, 2000; 343(10): 710 - 722. [Full Text] [PDF]
|
|
|
|
|
|
S. Schmulling, M. Grond, J. Rudolf, and W.-D. Heiss One-Year Follow-Up in Acute Stroke Patients Treated With rtPA in Clinical Routine Stroke, July 1, 2000; 31(7): 1552 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Albers, V. E. Bates, W. M. Clark, R. Bell, P. Verro, and S. A. Hamilton Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) Study JAMA, March 1, 2000; 283(9): 1145 - 1150. [Abstract] [Full Text] [PDF]
|
|